Sciensano provides epidemiological surveillance of rabies in Belgium and takes responsibility for diagnosis and treatment following exposure. It monitors the efficacy of vaccines against rabies. The Belgian Official Medicines Control Laboratory (OMCL) of Sciensano, together with the European OMCL network, is responsible for the quality control of the rabies vaccine prior to marketing.
